The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
Clinical trial NCT05789524 · TERMINATED
Trial details
- NCT number
- NCT05789524
- Sponsor
- ApcinteX Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2024-11-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.